Compositions and methods for protein glycosylation

Patent metadata

Field	Value
Publication number	US-10150952-B2
Application number	US-201515540690-A
Country	US
Kind code	B2
Filing date	Dec 24, 2015
Priority date	Dec 30, 2014
Publication date	Dec 11, 2018
Grant date	Dec 11, 2018

Abstract

Described herein are oligosaccharyl transferases for use in N-glycosylating proteins of interest in vitro and in host cells. Methods for using such oligosaccharyl transferases, nucleic acids encoding such oligosaccharyl transferases, and host cells comprising such oligosaccharyl transferases are also provided herein. Glycoconjugates generated by using such oligosaccharyl transferases are also provided herein.

First claim

What is claimed is:

1. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:1, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

2. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises two or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

3. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises a substitution at a position corresponding to position 311 of the polypeptide of SEQ ID NO: 1.

4. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase further comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of positions 287, 288, 289, 290, 291, 292, 293, and 294.

5. The N-oligosaccharyl transferase of claim 4 , wherein said N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of positions 287, 288, 289, and 294.

6. A nucleic acid encoding an N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:1, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

7. A host cell comprising the N-oligosaccharyl transferase of claim 1 .

8. A method of producing a bioconjugate comprising culturing the host cell of claim 7 in a cell culture medium, and purifying the bioconjugate from the host cell culture.

9. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO: 2, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488, and 489.

10. The N-oligosaccharyl transferase of claim 9 , wherein said N-oligosaccharyl transferase comprises two or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488 and 489.

11. The N-oligosaccharyl transferase of claim 9 , wherein said N-oligosaccharyl transferase comprises a substitution at a position corresponding to position 314 of the polypeptide of SEQ ID NO: 2.

12. A nucleic acid encoding an N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:2, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488, and 489.

13. A host cell comprising the N-oligosaccharyl transferase of claim 9 .

14. A method of producing a bioconjugate comprising culturing the host cell of claim 13 in a cell culture medium, and purifying the bioconjugate from the host cell culture.

Assignees

• Glaxosmithkline Biologicals Sa
• Glaxosmithkline Biologicals Sa

Inventors

• Haas Jurgen
• Ihssen Julian
• Kowarik Michael Thomas
• Schwede Torsten Franz
• Thöny-Meyer Linda Christiane

Classifications

• C12P21/005

  Glycopeptides, glycoproteins · CPC title

• C12N9/1081 Primary

  transferring other glycosyl groups (2.4.99) · CPC title

• Y02A50/30

  Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title